Prof Michaela Frye
German Cancer Research Center, DKFZ, Heidelberg, Germany.
Prof Michaela Frye Read More »
German Cancer Research Center, DKFZ, Heidelberg, Germany.
Prof Michaela Frye Read More »
A Director of Cancer Epigenetics Program, Chief of Division of Cancer Genomics & Epigenetics and Professor of Human Genetics.
Rob Martienssen is a Professor at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute.
Kristian Helin, CEO of The Institute of Cancer Research, professor at the University of London, research fellow at Harvard Medical School
Prof. Kristian Helin Read More »
Dr. Di Croce’s laboratory addresses the molecular basis of epigenetic alterations during the early phase of tumorigenesis.
Luciano Di Croce PhD Read More »
Clinician-scientist at the Peter MacCallum Cancer Centre and Centre for Cancer Research University of Melbourne.
Dr. Adam Myers is senior vice president and chief clinical transformation officer (CCTO) for the Blue Cross Blue Shield Association (BCBSA)
Dr. Sibel Blau is a Hematologist and Oncologist with expertise in breast cancer, multiple myeloma and stem cell transplant.
Dr. Elemento is a tenured full professor at Weill Cornell Medicine and the Director of the Caryl and Israel Englander Institute for Precision Medicine (EIPM)
Dr. Olivier Elemento Read More »
Mattias Rantalainen leads the Predictive Medicine group at Department of Medical Epidemiology and Biostatistics at Karolinska Institute in Sweden.
Mattias Rantalainen, Associate Professor, PhD Read More »